OR WAIT null SECS
BioPharm Systems announced that it is unveiling a new service to help life sciences companies maximize the return on investment for Oracle's Siebel Clinical Trial Management System (CTMS). The new BioPharm Systems Siebel Clinical Process Reengineering service extends the company's existing clinical trial management practice offerings.
BioPharm Systems' Siebel Clinical Process Reengineering service aims to allow sponsors and clinical research organizations to reduce cost, boost productivity, and increase compliance. After an analysis of a company's organizational structure, user roles and task divisions, training materials, standard operating procedures, and other process documentation that involve Siebel Clinical, BioPharm Systems will make sound recommendations for improving efficiencies around the use of their CTMS.
Members of BioPharm Systems' clinical trial management practice have been implementing Siebel Clinical since its inception and have experience in the system itself and in the best practices surrounding its use. The company's pre-configured and enhanced version of Siebel Clinical, ASCEND, was recently presented with the 2011 Innovation Award for Excellence in Technology in Health Sciences from the Oracle Health Sciences User Group. BioPharm Systems also recently received an Oracle PartnerNetwork North America Titan Awards Honorable Mention in the Oracle Accelerate for Midsize Companies category.